ANNX
Price
$6.99
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
61 days until earnings call
VIR
Price
$7.93
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
43 days until earnings call
Ad is loading...

ANNX vs VIR

Header iconANNX vs VIR Comparison
Open Charts ANNX vs VIRBanner chart's image
Annexon
Price$6.99
Change-$0.00 (-0.00%)
Volume$1.34M
CapitalizationN/A
Vir Biotechnology
Price$7.93
Change-$0.00 (-0.00%)
Volume$635.55K
CapitalizationN/A
View a ticker or compare two or three
ANNX vs VIR Comparison Chart
Loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ANNX vs. VIR commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a Hold and VIR is a Buy.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (ANNX: $6.99 vs. VIR: $7.93)
Brand notoriety: ANNX and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 119% vs. VIR: 86%
Market capitalization -- ANNX: $738.52M vs. VIR: $1.08B
ANNX [@Biotechnology] is valued at $738.52M. VIR’s [@Biotechnology] market capitalization is $1.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $609.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 0 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANNX and VIR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 5 TA indicator(s) are bullish while VIR’s TA Score has 6 bullish TA indicator(s).

  • ANNX’s TA Score: 5 bullish, 4 bearish.
  • VIR’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, VIR is a better buy in the short-term than ANNX.

Price Growth

ANNX (@Biotechnology) experienced а +11.84% price change this week, while VIR (@Biotechnology) price change was -0.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.17%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was -2.02%.

Reported Earning Dates

ANNX is expected to report earnings on Nov 18, 2024.

VIR is expected to report earnings on Oct 31, 2024.

Industries' Descriptions

@Biotechnology (+1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($1.08B) has a higher market cap than ANNX($739M). ANNX YTD gains are higher at: 53.965 vs. VIR (-21.173). ANNX has higher annual earnings (EBITDA): -124.62M vs. VIR (-525.76M). VIR has more cash in the bank: 1.15B vs. ANNX (369M). ANNX has less debt than VIR: ANNX (30.2M) vs VIR (115M). VIR has higher revenues than ANNX: VIR (57.6M) vs ANNX (0).
ANNXVIRANNX / VIR
Capitalization739M1.08B69%
EBITDA-124.62M-525.76M24%
Gain YTD53.965-21.173-255%
P/E RatioN/AN/A-
Revenue057.6M-
Total Cash369M1.15B32%
Total Debt30.2M115M26%
TECHNICAL ANALYSIS
Technical Analysis
ANNXVIR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 15 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTHAX47.440.28
+0.59%
FullerThaler Behavioral Sm-Cp Eq A
IPOAX19.090.08
+0.42%
Delaware Ivy Systematic Em Mkts Eq A
SPMVX8.490.03
+0.35%
Invesco SteelPath MLP Select 40 R5
LIFEX16.47-0.04
-0.24%
Domini Sustainable Solutions Ins
ICEVX42.55-0.30
-0.70%
NYLI Epoch International Choice Class A

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with MGTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
-2.31%
MGTX - ANNX
46%
Loosely correlated
+1.67%
FDMT - ANNX
41%
Loosely correlated
-1.94%
FULC - ANNX
40%
Loosely correlated
+9.75%
VIR - ANNX
40%
Loosely correlated
+0.76%
INZY - ANNX
39%
Loosely correlated
-2.67%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with TECH. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
+0.76%
TECH - VIR
50%
Loosely correlated
+0.70%
NTLA - VIR
48%
Loosely correlated
+4.83%
ABCL - VIR
48%
Loosely correlated
+1.87%
AVIR - VIR
48%
Loosely correlated
+3.34%
AXON - VIR
47%
Loosely correlated
-0.83%
More